Advertisement

Topics

PharmAbcine Inc. Company Profile

08:52 EDT 20th April 2018 | BioPortfolio

PharmAbcine is a leading clinical stage biologics company that develops fully human therapeutic antibody (mAb) and next generation multispecific antibody therapeutics based on in-house developed novel platform, DIG-Body, PIG-Body and TIG-Body using innovative discovery technology and excellent human resources for the treatment of human diseases, such as cancer and inflammatory diseases.


News Articles [5 Associated News Articles listed on BioPortfolio]

PharmAbcine and Merck evaluate TTAC0001/Keytruda combination

PharmAbcine Inc. and Merck & Co. Inc. entered into a trial collaboration to study the combination of PharmAbcine’s TTAC0001 (tanibirumab) with Merck’s Keytruda (pembrolizumab) as a potential new t...

PharmAbcine, Merck to assess TTAC-0001 in combination with Keytruda in recurrent rlioblastoma and breast cancer

PharmAbcine has signed a collaborative agreement with Merck (MSD) to evaluate its anti-VEGFR2 mAb, TTAC-0001, in combination with MSD’s anti-PD-1 (programmed death receptor-1) therapy, Keytruda (pem...

PharmAbcine Enters Collaboration with MSD Focused on Clinical Evaluation of TTAC-0001 in Combination with KEYTRUDA® (pembrolizumab) in Recurrent Glioblastoma and Breast Cancer

PharmAbcine Inc., a clinical-stage biotech company developing novel antibody therapeutics for multiple cancer indications, announces it has entered into a collaborative agreement ...

PharmAbcine Announces FDA Orphan Drug Designation Granted to TTAC-0001 for Glioblastoma Multiforme

PharmAbcine Inc., a clinical-stage biotech company developing novel antibody therapeutics for multiple cancer indications, announced today that U.S. Food and Drug Administration (...

PharmAbcine Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14032018] Prices from USD $250

SummaryPharmAbcine Inc PharmAbcine is a biotechnology company that discovers and develops human therapeutic monoclonal antibodies. The company offers lead MAB and bispecific MAB products. It provides ...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

PharmAbcine

PharmAbcine is a specialized biotech company that develops fully human therapeutic monoclonal antibody (mAb) using innovative discovery technology and excellent human resources for the treatment of hu...

PharmAbcine Inc.

PharmAbcine is a leading clinical stage biologics company that develops fully human therapeutic antibody (mAb) and next generation multispecific antibody therapeutics based on in-...

More Information about "PharmAbcine Inc." on BioPortfolio

We have published hundreds of PharmAbcine Inc. news stories on BioPortfolio along with dozens of PharmAbcine Inc. Clinical Trials and PubMed Articles about PharmAbcine Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of PharmAbcine Inc. Companies in our database. You can also find out about relevant PharmAbcine Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record